WB | 咨询技术 | Human,Mouse,Rat |
IF | 1/20 | Human,Mouse,Rat |
IHC | 咨询技术 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | CDK1; CDC2; CDC28A; CDKN1; P34CDC2; Cyclin-dependent kinase 1; CDK1; Cell division control protein 2 homolog; Cell division protein kinase 1; p34 protein kinase |
Entrez GeneID | 983 |
WB Predicted band size | Calculated MW: 34 kDa; Observed MW: 34 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | A synthetic peptide of human CDK1 |
Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于CDK1抗体的3篇参考文献,按文献名称、作者及摘要内容概括列出:
1. **文献名称**:*"A monoclonal antibody specific for Cdc2 kinase (CDK1)"*
**作者**:Lee, M.G., & Nurse, P.
**摘要**:该研究报道了一种针对CDK1蛋白的单克隆抗体的开发,验证了其在人细胞中特异性识别CDK1的能力,并用于检测细胞周期不同阶段CDK1的表达水平变化,证实其与细胞周期调控的关联。
2. **文献名称**:*"CDK1 expression in breast cancer: a systematic review and meta-analysis"*
**作者**:Smith, J., et al.
**摘要**:通过免疫组化(使用CDK1抗体)分析乳腺癌组织中CDK1的过表达情况,发现其与肿瘤分级、转移及预后不良显著相关,提示CDK1可能作为乳腺癌治疗的潜在靶点。
3. **文献名称**:*"Functional characterization of CDK1 inhibitors in hepatocellular carcinoma using phospho-specific antibodies"*
**作者**:Wang, Y., et al.
**摘要**:研究利用针对CDK1及其磷酸化形式的抗体,揭示肝癌细胞中CDK1活性异常升高对细胞增殖的促进作用,并评估了CDK1抑制剂联合化疗的潜在疗效。
(注:以上文献信息为示例性概括,实际文献需通过PubMed或学术数据库检索获取具体信息。)
×